Assignee
BAXALTA INC
US·89 granted patents·52 pending applications·295 citations·filing 2012–2024
Top patents by PatentIndex Score
141 records- 0198US9714411B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2015·Granted Jul 25, 2017·16 cites·18 claims
- 0297US11020458B2Factor VIII polymer conjugatesBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·1 claims
- 0397US10758599B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2019·Granted Sep 1, 2020·10 cites·28 claims
- 0496US9758568B2Oligopeptide-free cell culture mediaBAXALTA INC·Filed 2015·Granted Sep 12, 2017·10 cites·10 claims
- 0595US11020459B2Factor VIII formulationsBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·18 claims
- 0695US9809796B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 7, 2017·13 cites·19 claims
- 0795US9409971B2Method of producing recombinant high molecular weight vWF in cell cultureBAXALTA INC·Filed 2014·Granted Aug 9, 2016·15 cites·12 claims
- 0893US11197916B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2019·Granted Dec 14, 2021·9 cites·15 claims
- 0993US9731024B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2014·Granted Aug 15, 2017·9 cites·15 claims
- 1092US10209263B2Methods of measuring adamts 13 activityBAXALTA INC·Filed 2016·Granted Feb 19, 2019·5 cites·32 claims
- 1192US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 1292US9441216B2Cell culture medium for ADAMTS protein expressionBAXALTA INC·Filed 2015·Granted Sep 13, 2016·5 cites·25 claims
- 1391US10238720B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2018·Granted Mar 26, 2019·5 cites·30 claims
- 1491US10138461B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 27, 2018·2 cites·15 claims
- 1590US11081211B2Method and apparatus for providing a pharmacokinetic drug dosing regimenBAXALTA INC·Filed 2020·Granted Aug 3, 2021·9 cites·9 claims
- 1690US10738107B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggsBAXALTA INC·Filed 2016·Granted Aug 11, 2020·4 cites·11 claims
- 1790US10576160B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2017·Granted Mar 3, 2020·3 cites·15 claims
- 1890US10072254B2Cell culture methods for expressing ADAMTS13 proteinBAXALTA INC·Filed 2016·Granted Sep 11, 2018·3 cites·19 claims
- 1989US10414793B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2016·Granted Sep 17, 2019·4 cites·52 claims
- 2089US9937244B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2017·Granted Apr 10, 2018·4 cites·32 claims
- 2189US9708391B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2016·Granted Jul 18, 2017·3 cites·20 claims
- 2289US9572778B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2016·Granted Feb 21, 2017·4 cites·54 claims
- 2389US9492555B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2013·Granted Nov 15, 2016·7 cites·7 claims
- 2488US10232022B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2015·Granted Mar 19, 2019·9 cites·16 claims
- 2588US10125189B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXALTA INC·Filed 2015·Granted Nov 13, 2018·7 cites·18 claims
- 2688US9488651B2Methods of measuring ADAMTS 13 activityBAXALTA INC·Filed 2014·Granted Nov 8, 2016·3 cites·18 claims
- 2788US9468675B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2014·Granted Oct 18, 2016·4 cites·20 claims
- 2887US10632176B2Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWFBAXALTA INC·Filed 2018·Granted Apr 28, 2020·3 cites·19 claims
- 2987US9669076B2Albumin-free factor VIII formulationsBAXALTA INC·Filed 2016·Granted Jun 6, 2017·4 cites·13 claims
- 3087US2024335549A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2024·Application pending·0 cites
- 3186US10905746B2Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWFBAXALTA INC·Filed 2020·Granted Feb 2, 2021·2 cites·36 claims
- 3286US10822376B2Biologically active peptidesBAXALTA INC·Filed 2019·Granted Nov 3, 2020·1 cites·25 claims
- 3385US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 3485US10724024B2Cell culture methods for expressing ADAMTS proteinBAXALTA INC·Filed 2018·Granted Jul 28, 2020·1 cites·20 claims
- 3585US10350301B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2016·Granted Jul 16, 2019·4 cites·35 claims
- 3683US10723761B2Protein purification by anion exchange chromatographyBAXALTA INC·Filed 2017·Granted Jul 28, 2020·2 cites·17 claims
- 3783US9512198B2FVIII peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2015·Granted Dec 6, 2016·5 cites·20 claims
- 3882US11040109B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2019·Granted Jun 22, 2021·1 cites·29 claims
- 3982US9556260B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2014·Granted Jan 31, 2017·4 cites·31 claims
- 4081US9895434B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2016·Granted Feb 20, 2018·2 cites·12 claims
- 4180USD788936SPackaging unit for single medical deviceBAXALTA INC·Filed 2016·Granted Jun 6, 2017·26 cites·1 claims
- 4280US9556261B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Jan 31, 2017·3 cites·28 claims
- 4380US2022175939A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2022·Application pending·0 cites
- 4478US9732327B2Formulation of sugar solutions for continuous ultracentrifugation for virus purificationBAXALTA INC·Filed 2015·Granted Aug 15, 2017·2 cites·27 claims
- 4578US9303073B2Chimeric OspA proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted Apr 5, 2016·2 cites·17 claims
- 4677US10655099B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2018·Granted May 19, 2020·0 cites·18 claims
- 4777US9855331B2Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pHBAXALTA INC·Filed 2014·Granted Jan 2, 2018·1 cites·38 claims
- 4877US9334311B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted May 10, 2016·2 cites·20 claims
- 4976US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 5076USD788937SPackaging unit for single medical deviceBAXALTA INC·Filed 2016·Granted Jun 6, 2017·22 cites·1 claims
Showing the top 50 of 141 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BAXALTA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →